The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 11, 538-553
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (2017060201010155)
- National Natural Science Foundation of China (31471247)
- National Natural Science Foundation of China (81472832)
- National Natural Science Foundation of China (81772969)
This publication has 43 references indexed in Scilit:
- MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinomaNanomedicine: Nanotechnology, Biology and Medicine, 2017
- MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1Oncotarget, 2015
- Integrative analysis of 111 reference human epigenomesNature, 2015
- 14-3-3ζ Turns TGF-β’s Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2Cancer Cell, 2015
- An argument for mechanism-based statistical inference in cancerHuman Genetics, 2014
- Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor propertiesOncology Reports, 2014
- Cadmium Induces p53-Dependent Apoptosis Through the Inhibition of Ube2d Family Gene ExpressionNippon Eiseigaku Zasshi (Japanese Journal of Hygiene), 2012
- 14-3-3 Proteins: Diverse functions in cell proliferation and cancer progressionSeminars in Cell & Developmental Biology, 2011
- 14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell SurvivalCancer Research, 2009
- Epithelial–mesenchymal transition and tumour invasionThe International Journal of Biochemistry & Cell Biology, 2007